Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / IMUX - Immunic Inc. (IMUX) Q4 2023 Earnings Call Transcript


IMUX - Immunic Inc. (IMUX) Q4 2023 Earnings Call Transcript

2024-02-22 15:38:13 ET

Immunic, Inc. (IMUX)

Q4 2023 Earnings Conference Call

February 22, 2024, 8:00 AM ET

Company Participants

Jessica Breu - Vice President, Investor Relations and Communications

Daniel Vitt - Chief Executive Officer, President and Director

Glenn Whaley - Chief Financial Officer

Conference Call Participants

Caroline Pocher - Wedbush Securities

Nat Charoensook - Leerink Partners

Matthew Kaplan - Ladenburg Thalmann

Jun-Goo Kwak - Piper Sandler

William Wood - B. Riley Securities

Presentation

Jessica Breu

Good morning to everybody on the line. I would like to welcome you to Immunic's Fourth Quarter and Year End 2023 Earnings Call. My name is Jessica Breu, Vice President, Investor Relations and Communications at Immunic. I will also be the moderator today.

Speaking on the call are Dr. Daniel Vitt, our Chief Executive Officer and President; as well as Glenn Whaley, our Chief Financial Officer. Please note that all participants will be in listen-only mode, and this event is being recorded. After today's presentation, there will be an opportunity to ask questions. [Operator Instructions]

Before we begin, I would like to remind you that this presentation may contain forward-looking statements. Such statements can be identified by words such as may, will, expect, anticipate, estimate or words with a similar meaning, and such statements involve a number of risks and uncertainties that could cause Immunic's actual results to differ materially from those discussed here.

Please note that these forward-looking statements reflect Immunic's opinions only as of the date of this presentation, and it undertakes no obligation to revise or publicly release the result of any revision to these forward-looking statements in light of new information or future events. Please refer to Immunic's SEC filings for a more detailed description of the risk factors that may affect Immunic's results and these forward-looking statements....

For further details see:

Immunic, Inc. (IMUX) Q4 2023 Earnings Call Transcript
Stock Information

Company Name: Immunic Inc.
Stock Symbol: IMUX
Market: NYSE
Website: immunic-therapeutics.com

Menu

IMUX IMUX Quote IMUX Short IMUX News IMUX Articles IMUX Message Board
Get IMUX Alerts

News, Short Squeeze, Breakout and More Instantly...